Thiothixene, sold under the brand name Navane, is one of the lesser-known older antipsychotics. Chemically it belongs to the thioxanthene class — a small family of drugs related to the phenothiazines but built around a slightly different ring structure. Clinically, however, it behaves much like other high-potency first-generation antipsychotics, and patients and prescribers can think of it that way.
Thiothixene is a high-potency first-generation antipsychotic with a movement-heavy side effect profile and relatively mild metabolic burden — similar in feel to fluphenazine or haloperidol.
Where it sits
Like other high-potency typicals, thiothixene binds tightly to dopamine D2 receptors and has minimal histaminic, anticholinergic, or alpha-adrenergic activity. The result is the same general trade-off seen with haloperidol or fluphenazine: stronger on EPS, lighter on sedation, weight, and orthostasis. The StatPearls thiothixene review summarises the pharmacology and clinical use.
Movement side effects
Acute dystonia
Sudden involuntary muscle contractions, most often in the neck, jaw, or eyes. Usually appears in the first few days of treatment or after a dose increase. Treated with intramuscular benztropine or diphenhydramine.
Drug-induced parkinsonism
Tremor, rigidity, slowed movement, reduced facial expression. Typically appears over days to weeks. Often improves with a lower dose or with an added anticholinergic such as benztropine. See our EPS overview.
Akathisia
An inner restlessness driving constant movement, especially of the legs. Patients often describe it as worse than the underlying psychotic symptoms. Strategies include dose reduction, propranolol, or low-dose benzodiazepines. See our akathisia guide.
Tardive dyskinesia
Long-term involuntary movements of the face, mouth, and limbs. Risk rises with cumulative exposure. Annual AIMS exams are standard. See our TD article.
Hyperprolactinemia
Substantial prolactin elevation is common. Symptoms include menstrual changes, galactorrhoea, reduced libido, and erectile difficulties. Long-term elevation may contribute to bone density loss. See our hyperprolactinemia article.
Sedation and anticholinergic burden
Sedation is typically mild to moderate, less than chlorpromazine or thioridazine but more than haloperidol in some patients. Anticholinergic side effects (dry mouth, constipation, blurred vision, urinary hesitancy) are present but generally milder than with low-potency typicals. Adding an anticholinergic for EPS will increase these.
Metabolic effects
Weight gain on thiothixene is usually modest — comparable to other high-potency first-generation drugs and lighter than olanzapine or clozapine. Diabetes risk is lower than with the heaviest metabolic offenders.
Cardiovascular effects
Thiothixene can prolong the QTc interval modestly. Orthostatic hypotension is uncommon at standard doses. Combination with other QT-prolonging drugs needs care. See our QT prolongation article.
Neuroleptic malignant syndrome
High fever, severe muscle rigidity, confusion, sweating, fast heart rate, and unstable blood pressure occur together — possible NMS.
Less common but notable effects
- Photosensitivity — sunburn risk increases; use sunscreen
- Hepatic effects — uncommon liver enzyme elevations
- Blood dyscrasias — rare
- Lowered seizure threshold — modest
- Skin pigmentation changes — rare with newer phenothiazines and thioxanthenes, more historically associated with chlorpromazine
Who might do well on it
- People who responded to it historically
- People who need an inexpensive option
- People with strong concerns about metabolic side effects
- People who do not tolerate sedation from low-potency typicals
Who might not
- People with prior severe EPS or akathisia
- Older adults at higher TD risk
- People with cardiac conduction concerns
- People very sensitive to prolactin elevation
The big picture
Thiothixene is rarely the first choice in modern practice — second-generation drugs and newer LAIs have largely replaced it for new starts. But for patients who have done well on it for years, switching for the sake of switching is rarely worthwhile. The right plan is the one that respects what has worked, monitors for movement side effects attentively, and stays open to revision if the trade-offs change. That is a conversation for you and your prescriber, not a decision for any guideline.
This article is for educational purposes only and is not medical advice. Information is summarised from publicly available FDA labelling and peer-reviewed literature. Always consult your prescribing clinician before starting, stopping, or changing any medication.